6 Recruiting Studies Using Onvansertib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Onvansertib
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation
📍 Mayo Clinic - Arizona — Phoenix, Arizona
Metastatic Colorectal Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Onvansertib + Paclitaxel In TNBC
📍 Massachusetts General Hospital — Boston, Massachusetts
Breast Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
📍 University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland
Small-cell Lung Cancer
View Study & Checklist ➔ 🟢 Recruiting Early Phase1 💊 Investigational Drug / Biologic
Targeted Pathway Inhibition in Patients With Pancreatic Cancer
📍 OHSU Knight Cancer Institute — Portland, Oregon
Locally Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer
📍 The University of Kansas Cancer Center, Westwood Campus — Kansas City, Kansas
Pancreatic Cancer
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Recurrent Chronic Myelomonocytic Leukemia
View Study & Checklist ➔